Guide: Essential Principles & Practices for GPP Compliance: Engaging stakeholders in biomedical research during the era of COVID-19by Mesh Editorial Team
This tool from AVAC in intended to help guide stakeholder engagement in COVID-19 research. Built from the Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials (GPP), it responds to needs expressed by both researchers and advocates.
UNICEF C4D's Minimum quality standards and indicators in community engagement provide globally established guidance on the contribution of community engagement in development practice as well as humanitarian action.
This toolbox was developed in 2020 for the World Health Organisation COVID-19 Research Roadmap and provides a synthesis of key action points from the WHO GPP-EP guidelines. This “how to” guide gives an overview, tips and resources and will be updated as new resources are completed and approved.
U.S-based non-profit AVAC, is offering a useful set of webinars and resources looking at how rapid COVID-19 research can benefit from the lessons learned in the fight against HIV - including the importance of applying good participatory practice guidelines to ensure research is effective and inclusive
GPP-EP were prepared in 2016 by the WHO to support prevention and treatment trials of emerging (and re-emerging) pathogens that were likely to cause severe outbreaks. The guidelines address how to engage community stakeholders and promote ethical standards throughout the research process.
This toolbox was developed for the World Health Organisation COVID-19 Research Roadmap and shares information on establishing and working with different types of Community Advisory Boards/Groups (CAB/Gs) in the context of COVID-19 clinical studies.
This tool, developed by the site staff of the Microbicide Development Program in Tanzania, can be used to help community, trial participants, or staff members, prioritize issues and concerns central to the trial. This tool can serve as a platform to generate a list of potential issues and provide direction for what or which issues should take priority at the research site.
Using this tool, participants can raise and explore issues they perceive as priorities in HIV prevention research; discovering links between them. An interactive and fun way for community members and participants to be involved with the planning of HIV prevention research at the site.
GPP Strengths and Gaps is a facilitator’s guide for an exercise that is designed to help evaluate GPP implementation at a site level. It can be used with community and trial participants to garner honest feedback and constructive suggestions for improvements.
The AVAC Stakeholder Interview Questions is a tool that is designed for trial site staff. It guides members of the research team through the process of conducting a one-on-one interview with a stakeholder. The tool provides guidance for talking with many different types of stakeholders. It can be used to evaluate the impact of stakeholder engagement efforts.
The GPP Trial Site Binder is a companion tool to the Good Participatory Practice guidelines that research teams can use to help develop, organize and document the stakeholder engagement activity at the site. The binder is is divided into sixteen sections aligned with the guidelines. Each section contains key steps to help research staff follow the practices, templates for documenting and planning activities, and a place to file draft documents.
The GPP Blueprint is a companion to the Good Participatory Practice guidelines for biomedical HIV prevention research. It is a step-by-step guide designed for the research team members in charge of stakeholder engagement. It presents questions, worksheets and explanations that can guide and generate a stakeholder engagement plan for a specific trial or research program.
AVAC has developed a large set of supplementary tools to help research teams and other stakeholders understand, implement, and monitor the GPP guidelines. The GPP training tools can be used by anyone who wishes to conduct a training or to provide an overview of the GPP guidelines to a secondary audience.
The Red Cross and Red Crescent Movement has developed a hub to share our information, knowledge and resources about community engagement and accountability. Their COVID-19 area provides tools and resources to help incorporate community engagement and accountability into COVID-19 humanitarian operations
Guide: Empowering meaningful community engagement and involvement in global health research - critical reflections and guiding questionsby Erica Nelson, NIHR
This learning resource, from the UK's NIHR published in collaboration with the Institute of Development Studies, offers a brief set of reflections to help guide decision-making within the context of collaborative research approaches. It was published in March 2021 reflecting on the COVID-19 pandemic.
Teaming volunteer community members and research staff, this tool helps map out points of interest where key populations live, work, and access services. It can serve as a vehicle for community participation in the research process.
The Stakeholder Engagement Toolkit for HIV Prevention Trials, developed by FHI360, is a guide to engaging a wide range of key stakeholders throughout the trial lifecycle.
These offer an at-a-glance look at the GPP guidelines for individuals who may not be primarily responsible for implementing GPP, but who need to understand them. They are organized according to the stages of the trial life cycle: planning, trial conduct and post-trial. Each stage outlines GPP topic areas, highlights key practices, and lists considerations for various stakeholders
Although these Good Participatory Practice (GPP) Guidelines were developed by AVAC and UNAIDS for HIV prevention trials, they are valuable to clinical trials across fields, research areas, geographies and populations.
Providing guiding principles and practice standards for stakeholder engagement as an integral part of TB drug trials. Stakeholder engagement refers to any form of consultation, collaboration, and partnership put in place to enable a dialogue between all parties having a stake in a specific trial.
This report from Hilo Consultants Ltd outlines the key themes arising from a workshop session held in October 2020 which sought to look at ways of supporting strong practice in engagement within clinical trials.
Developed in Kenya, this toolkit can be used to support engagement with vaccine studies and particularly for COVID-19. These illustrated slides give a simplified scientific explanation of vaccine development, including the sequence and timeline for clinical studies, ethical review and randomisation.
The Global Code of Conduct for Research in Resource-Poor Settings aims to stop the export of unethical research practices to low and middle income countries.
Researchers funded by the NIHR Global Health Research Programme are expected to involve patients and the public in planning, implementation and evaluation of their research. This resource guide provides community engagement links, resources, references and learning to offer research teams and funding applicants a starting point
A code of ethics created by the San people of Africa for researchers wishing to study their culture.
This user friendly set of quantitative and qualitative monitoring and evaluation tools allows users to capture, collate and analyze Community and Stakeholder Engagement (CSE) data at the clinical trial site-level. The database is designed to support engagement teams working on clinical trials on a daily, monthly, quarterly and biannual basis.
These recommendations are intended as a tool to help research staff and community representatives expand and deepen existing partnerships, and forge new ones, with the ultimate goal of facilitating effective community engagement in all aspects of clinical trials research.